CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- 4 Planned sale Chief Development Officer sold 15,344 shares at $9.18 ($140,846)
- 4 Grant or award Chief Medical Officer acquired 118,750 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 182,870 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 112,750 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 127,750 shares (grant or award)
- 4 Grant or award President & CEO acquired 475,000 shares (grant or award)
- 4 Grant or award GRAMMER ELIZABETH A acquired 127,750 shares (grant or award)
- 4 Grant or award Felsch Robert Ora acquired 70,120 shares (grant or award)
- 4 Grant or award Blanks Robert acquired 112,750 shares (grant or award)
- 4 Planned sale Chief Development Officer sold 30,000 shares at $6.64 ($199,200)
- 4 Planned sale Chief Financial Officer sold 225,000 shares at $6.36 ($1,430,123)
- 4 Planned sale Chief Development Officer sold 5,675 shares at $6.07 ($34,447)
- 4 Planned sale Chief Development Officer sold 7,000 shares at $5.55 ($38,850)
- 4 Planned sale GRAMMER ELIZABETH A sold 50,000 shares at $5.08 ($253,925)
- 4 Planned sale Chief Development Officer sold 20,000 shares at $5.27 ($105,476)
- 4 Planned sale Chief Development Officer sold 10,272 shares at $5.00 ($51,360)
- 4 Planned sale Chief Development Officer sold 3,000 shares at $4.50 ($13,500)
- 4 Open-market sale Chief Medical Officer sold 2,581 shares at $4.36 ($11,259)
- 4 Open-market sale Chief Development Officer sold 3,767 shares at $4.36 ($16,432)
- 4 Open-market sale Chief Commercial Officer sold 4,714 shares at $4.36 ($20,563)
Page 10 of 35 · 690 filings